Agilent Technologies Stock Today

A Stock  USD 145.21  2.43  1.65%   

Performance

OK

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Agilent Technologies is trading at 145.21 as of the 8th of February 2025, a 1.65 percent decrease since the beginning of the trading day. The stock's open price was 147.64. Agilent Technologies has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Note, on November 11, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Agilent Technologies's common stock.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
18th of November 1999
Category
Healthcare
Classification
Health Care
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. The company has 285.29 M outstanding shares of which 3.46 M shares are presently sold short by investors with about 2.59 days to cover all short positions. More on Agilent Technologies

Moving together with Agilent Stock

  0.73DMAC DiaMedica TherapeuticsPairCorr

Moving against Agilent Stock

  0.68VERA Vera TherapeuticsPairCorr
  0.55DSGN Design TherapeuticsPairCorr
  0.42VANI Vivani MedicalPairCorr
  0.39DRRX DurectPairCorr
  0.31DRUG Bright Minds Biosciences TrendingPairCorr

Agilent Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOMichael McMullen
Thematic Ideas
(View all Themes)
Old Names[Armor Minerals Inc, Agilent Technologies Inc.]
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Stock Exchange Of, SP 500 Index, SRI Sustainable Growth, Healthcare, Measuring and Control Equipment, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Debt Levels
Agilent Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Agilent Technologies' financial leverage. It provides some insight into what part of Agilent Technologies' total assets is financed by creditors.
Liquidity
Agilent Technologies has accumulated 3.39 B in total debt with debt to equity ratio (D/E) of 0.52, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.99, which is considered satisfactory as compared to similar companies. Note however, debt could still be an excellent tool for Agilent to invest in growth at high rates of return.

Change To Inventory

32.13 Million
Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 and employs 17,400 people. Agilent Technologies is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current capitalization of 42.12 B. Agilent Technologies operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 285.29 M outstanding shares of which 3.46 M shares are presently sold short by investors with about 2.59 days to cover all short positions. Agilent Technologies has accumulated about 1.05 B in cash with 1.75 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.57.
Check Agilent Technologies Probability Of Bankruptcy
Ownership Allocation
Agilent Technologies holds a total of 285.29 Million outstanding shares. The majority of Agilent Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Agilent Technologies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Agilent Technologies. Please pay attention to any change in the institutional holdings of Agilent Technologies as this could imply that something significant has changed or is about to change at the company. On November 11, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Agilent Technologies's common stock.
Check Agilent Ownership Details

Agilent Stock Institutional Holders

InstituionRecorded OnShares
Jpmorgan Chase & Co2024-09-30
3.6 M
Brown Advisory Holdings Inc2024-09-30
3.6 M
Cantillon Capital Management Llc2024-09-30
3.3 M
Van Eck Associates Corporation2024-12-31
3.2 M
Nordea Investment Mgmt Bank Demark A/s2024-12-31
3.2 M
Generation Investment Management Llp2024-09-30
M
Ubs Asset Mgmt Americas Inc Usd2024-09-30
2.9 M
Ubs Asset Mgmt Americas Inc Usd2024-09-30
2.9 M
Legal & General Group Plc2024-09-30
2.9 M
Vanguard Group Inc2024-09-30
33.4 M
Blackrock Inc2024-09-30
26.3 M
View Agilent Technologies Diagnostics

Agilent Technologies Historical Income Statement

At present, Agilent Technologies' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.4 B, whereas Interest Expense is forecasted to decline to about 82.1 M. View More Fundamentals

Agilent Stock Against Markets

Agilent Technologies Corporate Directors

Daniel PodolskyIndependent DirectorProfile
Hans BishopIndependent DirectorProfile
George ScangosIndependent DirectorProfile
Sue RatajIndependent DirectorProfile

Already Invested in Agilent Technologies?

The danger of trading Agilent Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agilent Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agilent Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Agilent Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.569
Earnings Share
4.36
Revenue Per Share
22.269
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0758
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.